Tech Company Financing Transactions
ACT Biotech Funding Round
On 12/31/2009, ACT Biotech announced $500 thousand in funding from NGN Capital and private investors.
Transaction Overview
Company Name
Announced On
12/31/2009
Transaction Type
Venture Equity
Amount
$500,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
717 Market St.
San Francisco, CA 94103
USA
San Francisco, CA 94103
USA
Phone
Undisclosed
Website
Email Address
Overview
ACT Biotech is a biopharmaceutical company focused on the development and commercialization of cancer drugs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bernard Peperstraete
Browse more venture capital transactions:
Prev: 12/31/2009: Tabula Digita venture capital transaction
Next: 12/31/2009: Goodreads venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to document every notable VC transaction. VC investment data records reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs